Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR1H2 | P55055 | 7/20 | 0.50 |
| ▸ | NR1H3 | Q13133 | 7/20 | 0.50 |
| ▸ | IKBKB | O14920 | 1/20 | 0.45 |
| ▸ | CHUK | O15111 | 1/20 | 0.45 |
| ▸ | TOP2A | P11388 | 3/20 | 0.43 |
| ▸ | RXRA | P19793 | 1/20 | 0.43 |
| ▸ | CKS1B | P61024 | 5/20 | 0.42 |
| ▸ | SKP2 | Q13309 | 5/20 | 0.42 |
| ▸ | GLO1 | Q04760 | 3/20 | 0.41 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15863137 | 0.96 | NR1H2 (0.53) | NR1H2NR1H3IKBKBCHUKTOP2A | |
| SCHEMBL20725221 | 0.93 | NR1H2 (0.49) | NR1H2NR1H3IKBKBCHUKTOP2A | |
| SCHEMBL17773852 | 0.90 | NR1H2 (0.49) | NR1H2NR1H3IKBKBCHUKTOP2A | |
| SCHEMBL17773849 | 0.88 | NR1H2 (0.50) | NR1H2NR1H3IKBKBCHUKTOP2A | |
| SCHEMBL12131292 | 0.87 | TOP2A (0.46) | IKBKBCHUKTOP2ACKS1BSKP2 | |
| Sulfuric Acid SCHEMBL11349184 | 0.85 | TOP2A (0.51) | NR1H2NR1H3IKBKBCHUKTOP2A | |
| SCHEMBL9806108 | 0.82 | TOP2A (0.49) | NR1H2NR1H3IKBKBCHUKTOP2A | |
| SCHEMBL24514813 | 0.82 | IKBKB (0.47) | NR1H2NR1H3IKBKBCHUKTOP2A | |
| SCHEMBL338486 | 0.81 | LMNA (0.46) | IKBKBCHUKTOP2AGLO1TSHR | |
| SCHEMBL23607786 | 0.80 | TOP2A (0.47) | NR1H2NR1H3IKBKBCHUKTOP2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10203333-B2 | Electronically neutral metal complexes as biological labels | RUBIPY SCIENTIFIC, INC. (CA) | 2019-02-12 | — | — | US | disclosed |
| US-20160146826-A1 | Electronically Neutral Metal Complexes As Biological Labels | HUNAN SANSURE ACCUCISE BIOTECHNOLOGY CO., LTD. (CN) | 2016-05-26 | — | — | US | disclosed |
| WO-2014203067-A1 | ELECTRONICALLY NEUTRAL METAL COMPLEXES AS BIOLOGICAL LABELS | RUBIPY SCIENTIFIC, INC. (CA) | 2014-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10203333-B2 | Electronically neutral metal complexes as biological labels | MB, MCU, LETM1 | NR1H2 4880/4885NR1H3 4883/4885IKBKB 3218/4885 |
| US-20160146826-A1 | Electronically Neutral Metal Complexes As Biological Labels | MB, MCU, LETM1 | NR1H2 4880/4885NR1H3 4883/4885IKBKB 3218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.